3-MeO-PCP, or 3-Methoxyphencyclidine, is a potent dissociative research chemical that belongs to the arylcyclohexylamine class — the same chemical family as PCP and ketamine. It’s known for producing a unique balance of mental clarity and dissociation, making it a popular choice among researchers and experimental users alike.

• Chemical Profile: 3-MeO-PCP is structurally related to phencyclidine (PCP) but modified with a methoxy group, which reduces its sedative effects and increases its stimulating and euphoric properties. It acts primarily as an NMDA receptor antagonist.

• Dissociative Nature: It induces a state of disconnection from the physical environment and the self, commonly referred to as “dissociation.” This state can be either enlightening or disorienting, depending on the dose and setting.

• Stimulant-Euphoric Edge: Unlike ketamine, 3-MeO-PCP often brings a mild euphoria, enhanced sociability, and energetic sensations, making it unique among its class.

• Applications: While not approved for medical use, it’s frequently used in cognitive research and personal psychological exploration. Some users report increased introspection and insight.

• Potency Warning: It is active in sub-milligram to low milligram doses. As such, it should never be consumed without precise measuring tools.

• Global Legal Status: Its legality varies. Some countries have explicitly banned it, while others may not list it in controlled substance schedules.

• Research Status: Still undergoing investigation in experimental pharmacology and neuroscience due to its effects on memory, cognition, and NMDA-based signaling pathways.

The legality of 3-MeO-PCP depends heavily on your local, regional, and national laws. It is not universally scheduled, which means it may be legal in some jurisdictions and strictly banned in others. Psycho Plug encourages all customers to fully understand their local regulations before ordering.

• United States: 3-MeO-PCP is not currently federally scheduled but is controlled in several individual states such as Alabama, Arkansas, and Florida, among others. It’s typically prohibited under analogue acts if used for human consumption.

• Canada: Classified as a Schedule I substance, meaning it is fully illegal to possess, produce, or distribute.

• United Kingdom: Listed under the Misuse of Drugs Act as a Class B substance, making possession and supply illegal.

• Australia and New Zealand: Often captured under analogue or psychoactive substance laws, though specific listings can vary by territory or interpretation.

• European Union: Laws vary between countries. Germany, Sweden, and others have included it in their controlled substances lists, while other EU nations may not have formal restrictions yet.

• Research-Only Sales: Some countries may allow purchase for scientific or chemical research purposes but not for personal use.

• Psycho Plug’s Policy: We ship worldwide, but customers are responsible for ensuring compliance with local laws. We offer discreet shipping, but cannot guarantee clearance if your country strictly prohibits this compound.

Storing 3-MeO-PCP properly ensures it maintains its potency, chemical stability, and overall integrity. As with most sensitive research chemicals, it requires specific conditions to avoid degradation or contamination.

• Cool, Stable Temperature: Store the substance in a temperature-controlled environment, ideally below 25°C (77°F). Avoid areas near windows or heat-emitting devices.

• Dry Conditions: Keep 3-MeO-PCP in a dry place. Exposure to moisture can lead to hydrolysis and degrade the compound. Avoid storing it in bathrooms or kitchens.

• Dark Environment: UV light can alter chemical bonds. Store it in a dark container or a drawer to prevent photodegradation.

• Vacuum-Sealed or Airtight Containers: Use glass or plastic containers with airtight seals. Double-bagging in vacuum-sealed pouches adds extra protection.

• Avoid Frequent Opening: Minimize exposure to air by opening the container only when needed. Each exposure to air can accelerate oxidation.

• Label Clearly: Use tamper-evident labels with chemical names, concentrations, and dates to ensure safety and traceability.

• Keep Away from Children and Pets: Always store in a locked cabinet or hidden area inaccessible to unauthorized individuals.

3-MeO-PCP is extremely potent, and even small miscalculations can lead to intense or overwhelming experiences. Dosages should be measured with high-precision equipment, and users should always start at the lowest threshold possible.

• Threshold Dose: 0.5–1 mg. At this range, effects are minimal but noticeable in terms of mental alertness and slight sensory distortion.

• Light Dose: 1–2.5 mg. Mild dissociation may occur, often described as increased clarity, slight detachment, and enhanced thought flow.

• Moderate Dose: 3–5 mg. Stronger dissociative effects begin, including a pronounced separation from bodily awareness and shifts in time perception.

• High Dose: 6–10 mg. At this level, effects can be very intense — expect full dissociation, limited physical coordination, and potential ego loss.

• Overdose Threshold: 10+ mg. Beyond this, the risk of physical disconnection, manic episodes, or hospitalization increases. Not recommended without experience and a sober sitter.

• Dosing Routes: Oral ingestion is slower and smoother. Insufflation (nasal use) leads to faster onset and more intense effects, but can irritate mucous membranes.

• Volumetric Dosing: Dissolving in alcohol or propylene glycol allows more accurate micro-measuring — especially useful for microdoses or research-grade tracking.

• Safety First: Always use a milligram scale (0.001g precision), never eyeball, and allow several hours between redosing to avoid stacking effects.

The duration of 3-MeO-PCP’s effects depends on the dosage, route of administration, and individual physiology. Generally, its effects are longer-lasting than ketamine but shorter than PCP, offering a middle ground for dissociative research.

• Onset Time: Oral ingestion typically takes 20 to 40 minutes to begin, while insufflation (nasal) starts within 5 to 15 minutes.

• Peak Effects: Reached around 1 to 2 hours after administration. At this stage, users may experience vivid introspection, emotional detachment, or complete ego dissolution.

• Plateau Duration: The main dissociative phase usually lasts 3 to 6 hours, depending on dose and personal tolerance.

• Come-down Period: Lasts another 2 to 4 hours. During this time, users may feel emotionally reflective, mentally sharp, or slightly fatigued.

• Afterglow: A subtle positive or neutral cognitive “glow” can last for 12–24 hours, often marked by calmness, reduced anxiety, or residual stimulation.

• Sleep Interference: High doses late in the day may delay or disrupt sleep patterns.

• Tolerance Consideration: Repeated use within short periods can lead to reduced effect duration and increased dosage requirements.

While many individuals report positive and enlightening experiences with 3-MeO-PCP, it is a powerful dissociative with a wide range of physical and psychological side effects. The intensity and type of effects depend heavily on dosage, setting, and the user’s mental and physical health.

• Cognitive Disorientation: At moderate to high doses, users may experience difficulty thinking clearly, confusion, short-term memory loss, or looping thought patterns. This cognitive fog can last beyond the peak effects in some cases.

• Motor Control Impairment: 3-MeO-PCP can cause unsteady gait, slowed reflexes, and difficulty performing fine motor tasks. At high doses, movement may become robotic or severely uncoordinated.

• Emotional Detachment or Blunting: Some users report temporary emotional flattening or apathy. This can be disconcerting if not anticipated and may last several hours after the peak has passed.

• Stimulating Effects and Insomnia: Unlike ketamine, 3-MeO-PCP can be physically stimulating. Users may experience increased heart rate, alertness, or restlessness, especially if taken late in the day.

• Mania or Hypomania: High doses may induce manic or euphoric states, including excessive talking, elevated mood, or impulsivity. This is particularly dangerous for individuals with bipolar tendencies.

• Aggression or Irritability: In rare instances, particularly with overdoses, individuals may become agitated or hostile. These effects are typically short-lived but can be alarming.

• Urinary and Bladder Concerns: With repeated high-dose use, there may be some risk of bladder irritation similar to what is seen in ketamine users, although this is not well-documented for 3-MeO-PCP.

Although 3-MeO-PCP does not produce classic physical dependence, it does carry a risk of psychological addiction. Users should be aware of the signs of habitual use and practice strict moderation.

• High Abuse Potential: Because of its euphoric and stimulating properties, 3-MeO-PCP can be tempting to reuse frequently, which may lead to compulsive patterns.

• Rapid Tolerance Buildup: With repeated use, the brain adjusts quickly, leading to diminishing effects and increasing the temptation to escalate the dose. Tolerance may develop after just a few uses.

• Psychological Craving: Users may begin to crave the feeling of clarity, detachment, or euphoria it provides, particularly if they use it to escape emotional distress or boredom.

• Impaired Judgment: One of the hallmarks of dissociatives is a false sense of control. Users may believe they are unaffected and capable of functioning normally, increasing the risk of accidents or continued use.

• Withdrawal Effects: While there are no severe physical withdrawal symptoms, heavy users report rebound anxiety, brain fog, insomnia, and depression after stopping prolonged use.

• Harm Reduction: It’s essential to keep usage occasional, track frequency, and take long breaks between sessions. Setting personal limits or having a trusted sitter can help prevent misuse.

• Support Options: If addiction is suspected, seeking help from harm reduction communities or professional support services is strongly recommended.

Although both 3-MeO-PCP and ketamine are classified as dissociatives and act primarily through NMDA receptor antagonism, they produce very different subjective experiences and pharmacological effects. Understanding these differences is crucial for users deciding which compound better fits their intentions or research.

• Duration of Effects: Ketamine is shorter-acting, typically 1–2 hours, while 3-MeO-PCP lasts much longer — around 4–8 hours, sometimes more.

• Mental Clarity: 3-MeO-PCP is often described as producing a more “lucid” or mentally stimulating dissociation, whereas ketamine induces a dreamy or foggy state of detachment.

• Euphoric Qualities: While both can induce euphoria, 3-MeO-PCP tends to produce a stronger emotional uplift and more pronounced feelings of power or confidence.

• Body Load: Ketamine is more likely to induce physical immobility or the “k-hole” experience, making it harder to move or speak. 3-MeO-PCP often retains motor function at moderate doses.

• Therapeutic Use: Ketamine has approved medical applications (e.g., anesthesia, treatment-resistant depression). 3-MeO-PCP is strictly a research chemical and not approved for clinical use.

• Addiction Risk: Both can lead to habitual use, but ketamine has more documented evidence of physical harm, such as bladder issues, in long-term users.

• Social Functionality: 3-MeO-PCP, at lower doses, may enhance social interaction and conversation, while ketamine often makes users withdrawn or introspective.

3-MeO-PCP primarily affects the brain by blocking NMDA (N-methyl-D-aspartate) receptors, which are critical for excitatory neurotransmission, learning, and memory. This interference with glutamate signaling leads to its dissociative and psychoactive properties.

• NMDA Receptor Antagonism: By inhibiting NMDA receptor activity, 3-MeO-PCP disrupts normal neural communication, creating a sense of detachment from self and surroundings.

• Altered Sensory Perception: Users often experience time dilation, spatial distortions, and changes in tactile or auditory processing. These effects result from altered signaling in cortical regions.

• Cognitive Detachment: In high doses, the compound can disconnect the brain’s sensory input from the perception of reality, causing profound dissociation or ego loss.

• Mood Regulation: NMDA receptor antagonism is also linked to mood elevation and emotional numbing. These effects may mimic antidepressant action but are unpredictable.

• Memory Disruption: Temporary memory fragmentation is common, especially during peak effects. Users may forget parts of the experience or have trouble forming new memories.

• Neuroplasticity Effects: Some early research suggests dissociatives might enhance or suppress neuroplasticity, though the long-term cognitive impact of 3-MeO-PCP remains unclear.

• Dose-Dependent Risk: Low doses affect cortical connectivity subtly, while high doses significantly impair sensory integration and executive function.

Mixing 3-MeO-PCP with other substances is strongly discouraged unless you are highly experienced and fully aware of the risks. Its interaction profile is complex and can result in severe or unpredictable effects, including medical emergencies.

• Alcohol and Depressants: Combining 3-MeO-PCP with alcohol, benzodiazepines, or opioids increases the risk of respiratory depression, blackouts, and dangerous sedation.

• Stimulants (e.g., cocaine, amphetamines): These combinations may produce agitation, paranoia, or psychosis. The stimulant-dissociative mix puts immense stress on the heart and nervous system.

• Other Dissociatives (e.g., ketamine, DXM): Stacking dissociatives can intensify disconnection, impair coordination severely, and prolong recovery. It also raises the risk of urinary tract toxicity.

• Psychedelics (e.g., LSD, psilocybin): Combining with classic psychedelics can result in overwhelming or chaotic experiences. The introspective depth may be increased but so are confusion and emotional volatility.

• Cannabis: While mild cannabis use may smooth the come-up or come-down, it can also intensify dissociation and lead to anxiety or panic, especially in high doses.

• Prescription Medications: Many pharmaceuticals can interact dangerously with 3-MeO-PCP, especially antidepressants, antipsychotics, and seizure medications.

• Safe Practice: If you are determined to combine substances, research each interaction thoroughly, use tiny amounts, and always have a sober trip sitter present. Psycho Plug advises against mixing altogether.

Measuring 3-MeO-PCP accurately is crucial due to its high potency at extremely low doses. Small measurement errors can drastically change the experience from mild dissociation to overwhelming intoxication, making precision non-negotiable for safe and responsible use.

• Use a Milligram-Accurate Scale: A precision scale that measures down to 0.001g (1mg) is essential. Cheaper scales with only 0.01g (10mg) resolution are not suitable for dosing 3-MeO-PCP.

• Calibrate the Scale Properly: Before each session, ensure your scale is calibrated using official calibration weights. This avoids discrepancies that could lead to accidental overdosing.

• Weigh Doses Individually: Always measure each dose separately. Never assume that a previous dose was accurate, and never measure by “eyeballing” or by volume (e.g., teaspoon).

• Volumetric Dosing Method: Dissolving 3-MeO-PCP in a known volume of solvent (such as ethanol or propylene glycol) allows for precise microdosing. For example, dissolving 100 mg in 100 ml provides a 1 mg/ml solution.

• Label and Store Carefully: If preparing volumetric solutions, label them clearly with the date, concentration, and solvent used. Store securely away from others and children.

• Avoid Cross-Contamination: Always clean the scale tray, tools, and containers between uses. Cross-contamination with other substances or residues can compromise accuracy and safety.

• Test New Batches Cautiously: Potency may vary between batches. Always start low, even if you’re experienced, to assess strength and purity.

xMicrodosing with 3-MeO-PCP is uncommon and should be approached with extreme caution due to its potency and unpredictable psychological effects. While some users experiment with sub-perceptual doses for focus or introspection, the risks may outweigh the benefits.

• Typical Microdose Range: Microdoses typically range from 0.2 mg to 0.5 mg. These amounts are below the dissociative threshold and may subtly affect mood or cognition.

• Requires Advanced Measurement: Only volumetric dosing or extremely sensitive scales should be used. Even 0.5 mg too much can tip the dose into active territory.

• Effects Reported: Users describe increased verbal fluency, mood elevation, and enhanced focus. Others report mild confusion, disconnection, or irritability — even at microdose levels.

• Duration Still Long: Despite the low dose, 3-MeO-PCP can still last several hours, which is longer than typical microdosing agents like LSD or psilocybin.

• Not Well-Studied: Unlike LSD microdosing, which has growing clinical interest, 3-MeO-PCP has not been studied for therapeutic microdosing and remains speculative.

• Addiction Risk Remains: Regular microdosing, even with small amounts, may still lead to tolerance or psychological dependence over time.

• Safer Alternatives Exist: Other substances (e.g., low-dose ketamine in clinical settings) have better research backing and less risk of cognitive fog or disinhibition.

An overdose of 3-MeO-PCP can be serious and requires immediate attention. While fatalities are rare, high doses can lead to intense dissociation, psychosis, loss of control, or dangerous behavior. Knowing how to respond can reduce harm significantly.

• Do Not Panic: Stay calm and reduce sensory stimulation. Move to a quiet, safe space with minimal lights, sounds, and interaction.

• Avoid Additional Substances: Do not attempt to counteract the overdose with alcohol, sedatives, or stimulants. These combinations can worsen the situation or mask symptoms.

• Stay Hydrated: If the person is able to drink water, encourage slow sips to prevent dehydration. Avoid forcing liquids if they are vomiting or unresponsive.

• Have a Sitter Present: A sober and trusted person should supervise the affected individual. Their presence can prevent accidents and offer emotional reassurance.

• Watch for Severe Symptoms: Signs of medical emergency include erratic heart rate, hyperthermia, seizures, or violent behavior. If these occur, seek medical help immediately.

• Be Honest with Medical Staff: If emergency services are required, inform them of the exact substance and approximate dose taken. This speeds up and improves treatment accuracy.

• Aftercare: Once stabilized, allow several days for recovery. Mental exhaustion, confusion, or depression may linger and should be taken seriously.

While not clinically approved for therapeutic use, some psychonauts explore 3-MeO-PCP for personal psychological breakthroughs. Its dissociative clarity, emotional numbing, and enhanced introspection can mimic elements of psychedelic-assisted therapy — but the risks are substantial.

• Not Medically Sanctioned: Unlike ketamine, which is FDA-approved for depression treatment in clinical settings, 3-MeO-PCP has no recognized medical or psychiatric applications.

• Self-Therapy Reports: Some users report confronting repressed trauma or engaging in reflective self-dialogue. Dissociation can help people view personal issues more objectively.

• High Risk of Misuse: Without a therapeutic framework or professional guidance, users may misinterpret experiences, engage in self-harm, or develop delusional thinking.

• Emotional Numbing: While emotional detachment can facilitate tough introspection, it may also lead to avoidance or disconnection from essential feelings.

• Unpredictable Outcomes: Emotional effects can shift quickly from clarity to confusion. Manic or depressive episodes are possible during or after the experience.

• No Controlled Dosing: In therapeutic settings, dosage is carefully managed. With 3-MeO-PCP, small measurement errors can derail an intended therapeutic session.

• Safer Options Available: Legal ketamine clinics and supervised psychedelic trials offer far safer paths to healing. Psycho Plug does not endorse unsupervised therapy.

3-MeO-PCP is not ideal for beginners due to its high potency, long duration, and potential for psychological unpredictability. Novice users may underestimate its effects, leading to discomfort or dangerous behavior.

• Low Dose Threshold: With active doses starting around 1 mg, new users may find it difficult to dose accurately without proper equipment and experience.

• Long-Lasting Effects: Unlike shorter-acting compounds like DMT or ketamine, 3-MeO-PCP can last 6–12 hours or more, which can be overwhelming for first-timers.

• Delayed Onset: New users may re-dose too soon if they don’t feel effects immediately, leading to accidental overdosing or stacking.

• Strong Psychological Shifts: Beginners may find the emotional and cognitive detachment unfamiliar or frightening, especially in unsupervised or unsafe settings.

• Risk of Mania or Delusion: First-time users are more vulnerable to overestimating their control during peak states, potentially resulting in impulsive actions.

• Best Practices for First Use: If a beginner chooses to try 3-MeO-PCP, they should start with ≤1 mg, have a sober sitter present, and stay in a calm, private environment.

• Safer Starter Options: Less intense dissociatives, such as sub-perceptual ketamine doses or lighter psychedelics like LSD microdoses, may offer a more controlled entry point.